ScholarIQanswers from OpenAlex

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease

PaperCitations, authors & open-access status

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease have?

ScholarIQcitation count

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease has 32 citations in the OpenAlex counts ScholarIQ stores.

When was Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease published?

ScholarIQyear

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease has 2017 year in the ScholarIQ index.

What is the open-access status of Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease?

ScholarIQoa status

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease has gold oa status in the ScholarIQ index.

What is the DOI of Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease?

ScholarIQdoi

The DOI for Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease is on the source record.

What is the PMID of Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease?

ScholarIQpmid

The PMID for Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease is on the source record.

What is the OpenAlex record for Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease?

ScholarIQopenalex

The OpenAlex for Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease is on the source record.

Related on ScholarIQ

Funders

470M+ articles · 14-day free trial